ENTITY
Shandong Xinhua Pharmaceutical

Shandong Xinhua Pharmaceutical (719 HK)

114
Analysis
Health Care • China
Shandong Xinhua Pharmaceutical is a Chinese company specializing in the development, production, and distribution of chemical bulk drugs, pharmaceutical preparations, and medical intermediates. It is a leading global manufacturer and exporter of antipyretics and analgesics, as well as drugs for the central nervous system, steroids, and cardio cerebrovascular system. The company was established in 1943 and is headquartered in Zibo, Shandong, China.
more
•31 Dec 2021 18:33

A/H Premium Weekly: Industrials Led Premium Increase

Top three sectors in terms of A/H premium increase were consumer stable, utilities and industrials. Six industrial names appeared in the top 10 A/H...

Logo
710 Views
Share
•03 Dec 2021 16:59

A/H Premium Weekly: Angang Steel, Zoomlion, BBMG at 52 Week High

We highlight stocks that reached 52 week high of A/H premium last week: Angang Steel (347 HK), Zoomlion (1157 HK) and BBMG (2009 HK).

Logo
514 Views
Share
•17 Jun 2019 07:16

Hansoh Pharma (翰森制药) Post-IPO Trading Update: Fairly Valued

Hansoh Pharma's IPO was priced at the high end and started trading last Friday. In our earlier note, we argued that the company should trade at...

Logo
715 Views
Share
bullish•Tencent
•16 Apr 2019 10:17

HK Connect Ideas: Tencent Inflows Not Sustained After Game Approval (2019-04-12)

In our weekly HK Connect Ideas series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
846 Views
Share
•08 Apr 2019 16:42

HK Connect Discovery Weekly: Air China and Great Wall Motor (2019-04-04)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
823 Views
Share
x